Catellani, S., Pierri, I., Gobbi, M., Poggi, A., & Zocchi, M. R. (2011). Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia. Public Library of Science (PLoS).
Style de citation Chicago (17e éd.)Catellani, Silvia, Ivana Pierri, Marco Gobbi, Alessandro Poggi, et Maria Raffaella Zocchi. Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-leukemic Reactivity in Patients with Chronic Myelogenous Leukemia. Public Library of Science (PLoS), 2011.
Style de citation MLA (8e éd.)Catellani, Silvia, et al. Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-leukemic Reactivity in Patients with Chronic Myelogenous Leukemia. Public Library of Science (PLoS), 2011.